Viking Therapeutics VKTX

$ 42.5 2.43%

Quarterly report 2024-Q3
added 10-23-2024

Viking Therapeutics EV/EBITDA Ratio 2011-2024 | VKTX

Annual EV/EBITDA Ratio Viking Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-5.23	-12.9 K	-13.7	-21	-6.71	-1.75	-0.651	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.651	-12.9 K	-1.85 K